positive living with MS
Please select your professional status below if you are a medical professional or click here to return to the msactivesource.co.uk website if you are not.
Clicking on the relevant title certifies that you are a healthcare professional accessing in your capacity as a healthcare professional.
MS Nurse...click here
Nurse...click here
Doctor...click here
MS Specialist...click here
You are leaving www.msactivesource.co.uk, a web site of Biogen Idec UK & Ireland. Links to all outside web sites are provided as a resource to our visitors. Biogen Idec accepts no responsibility for the content of other web sites.
If you are diagnosed with MS, your neurologist will discuss the available treatment options with
you. There are two main types of treatment:
While there are no cures for MS, these treatments help patients live with the disease.
As discussed further in the Treatment section of this website, intravenous corticosteroids can be given to help relieve symptoms of attack. Other options are also available to treat specific symptoms. However, these treatments have no effect on the overall course of MS and are only taken during an attack.
In contrast, disease-modifying therapies (DMT) have been shown to slow the progression of disease for patients with relapsing-remitting MS. These agents are taken continuously from diagnosis and can be taken for as long as the patient appears to be benefiting. Since they aim to influence the overall course of the disease, it is important that patients continue to take these therapies even if they are in remission. The available DMTs are: interferon-beta (IFN-beta), glatiramer acetate, which are self administered and natalizumab, given by intravenous infusion as described in the Treatment section of this website.
A number of specialist health professionals can also assist the patient in living with MS. These
include:
Further information on treatment can be found on the following websites: MS Society and the MS Trust. In addition, guidelines on the management of MS have been drawn up by the Association of British Neurologists (ABN) (ref m23) and the National Institute of Clinical Excellence (NICE) (ref m22) which are available online.
We are not responsible for the content of external sites. Please read our legal disclaimer.
Multiple Sclerosis is a disease of unknown origin that affects the central nervous system.
Supported by
This website is intended for use in Great Britain and Northern Ireland.
Please click here for msactivesource.ie
Page last updated: 22 Jun 2010
|
| This site complies to the HONcode standard for trustworthy health information: verify here. |